Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Harnessing the vulnerabilities of p53 mutants in lung cancer - Focusing on the proteasome: a new trick for an old foe?
Cancer Biol Ther. 2020 Apr 2;21(4):293-302. doi: 10.1080/15384047.2019.1702403. Epub 2020 Feb 10.
Cancer Biol Ther. 2020.
PMID: 32041464
Free PMC article.
Review.
Proteasome inhibition paradoxically degrades gain-of-function mutant p53 R273H in NSCLC and could have therapeutic implications.
Oduah EI, Sharfstein ST, Seetharamu N, Grossman SR, Litovchick L.
Oduah EI, et al.
Front Oncol. 2024 Apr 10;14:1363543. doi: 10.3389/fonc.2024.1363543. eCollection 2024.
Front Oncol. 2024.
PMID: 38660140
Free PMC article.
Item in Clipboard
The emerging landscape of EFGR tyrosine kinase inhibitors in lung adenocarcinoma-successes and challenges.
Oduah EI, Lee CS, Seetharamu N.
Oduah EI, et al.
J Thorac Dis. 2022 Jun;14(6):1766-1771. doi: 10.21037/jtd-22-432.
J Thorac Dis. 2022.
PMID: 35813761
Free PMC article.
No abstract available.
Item in Clipboard
Heparin: Past, Present, and Future.
Oduah EI, Linhardt RJ, Sharfstein ST.
Oduah EI, et al.
Pharmaceuticals (Basel). 2016 Jul 4;9(3):38. doi: 10.3390/ph9030038.
Pharmaceuticals (Basel). 2016.
PMID: 27384570
Free PMC article.
Review.
Item in Clipboard
Cite
Cite